MENU
NAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Niagen Bioscience (NAGE) Ownership - Who owns Niagen Bioscience?
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
795.93M
P/E Ratio
45.36
Total Cash
60.32M
Projected Growth
N/A
Total Debt
3.29M
Revenue
116.3M
Risk (Beta)
2.62
Dividend Yield
N/A
Total Cash/Share
0.76
Total Debt/Equity
N/A
Revenue/Share
1.40 USD as % of share price
Fundamentals
NAGE
Capitalization
796M
P/E Ratio
45.36
Risk (Beta)
2.62
Dividend Yield
N/A
Total Cash
60.3M
Total Cash/Share
0.76
Total Debt
3.29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.40%
Revenue
116M
ROE
N/A
Book Value
64.2M
P/B Ratio
12.39
Cash Flow
N/A
Earnings
0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
79K
Current Ratio
3.88
Current Revenue Per Employee
299201.94
Dividends Per Share - Security
N/A
EBITDA
18.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.00
Revenue To Assets
24.36
Shares Held By Institutions
401M
Shares Outstanding - Current
79.8M
Total Liabilities
27.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
88.124
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAGE showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of proprietary-based ingredient technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A